CompletedNot Applicable

ACTIVATE in Public Housing

United States400 participantsStarted 2024-07-01

Plain-language summary

This multilevel, multidisciplinary, theoretically based, culturally sensitive, community-engaged intervention sets out to mitigate uptake barriers and non-adherence to vaccination schedules as recommended by the CDC and increase influenza, meningitis, pneumonia, VZV, and COVID-19 vaccine rates among under-resourced African American and Latino public housing residents in South Los Angeles.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Aim 3: Inclusion Criteria: * identify as Latinx or African American * age 18 or older * reside in one of the six collaborating public housing area * Speak either English or Spanish * Report vaccine hesitancy Exclusion Criteria: * Not a resident at one of the collaborating public housing areas * Does not self-identify as African American or Latinx * Age 17 and younger * Unable to speak either English or Spanish * Received all recommended vaccines for Influenza, Pneumonia, Meningitis, VZV, and COVID-19 * No reporting of vaccine hesitancy

What they're measuring

Prevalence of vaccination uptake for Influenza, Pneumonia, Meningitis, VZV, and COVID-19 using Vaccination History Self Report

Timeframe: Intervention: 8 months; Follow-up Point: 3- and 9-months post-intervention

Trial details

NCT IDNCT06075732

SponsorCharles Drew University of Medicine and Science

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-30

View on ClinicalTrials.gov More Pneumonia trials